TickerFactsScreenerDevelopers

Lexaria Bioscience Corp. (LEXX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $45.6K2017: $29.8K2018: $25.2K2019: $22.9K2020: $99.4K2021: $175.3K2022: $71.8K2023: $31.5K2024: $4.8K2025: $2.7K$2.7K
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$2.7K-43.6%
2024$4.8K-84.7%
2023$31.5K-56.2%
2022$71.8K-59.0%
2021$175.3K+76.4%
2020$99.4K+334.1%
2019$22.9K-9.1%
2018$25.2K-15.3%
2017$29.8K-34.8%
2016$45.6K—